Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorptionRABITSCH, W; KNÖBL, P; PRINZ, E et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 10, pp 1015-1019, issn 0268-3369, 5 p.Article

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSFBASAK, G. W; WIKTOR-JEDRZEJCZAK, W; LEMOLI, R et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 7, pp 1003-1005, issn 0268-3369, 3 p.Article

Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)REITER, E; GREINIX, H; MITTERBAUER, G et al.Annals of hematology (Print). 2000, Vol 79, Num 7, pp 374-377, issn 0939-5555Article

Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors : a cross-sectional studyLEITNER, G. C; BAUMGARTNER, K; KALHS, P et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 5, pp 357-363, issn 0268-3369, 7 p.Article

Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myelomaWOREL, N; GREINIX, H; ACKERMANN, J et al.Annals of hematology (Print). 2001, Vol 80, Num 6, pp 345-348, issn 0939-5555Article

Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective studyKUZMINA, Z; EDER, S; JUST, U et al.Leukemia. 2012, Vol 26, Num 4, pp 746-756, issn 0887-6924, 11 p.Article

Mechanisms underlying acquired von Willebrand syndrome associated with an IgM paraproteinMAYERHOFER, M; HAUSHOFER, A; KYRLE, P. A et al.European journal of clinical investigation. 2009, Vol 39, Num 9, pp 833-836, issn 0014-2972, 4 p.Article

Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic featuresKAUFMANN, H; ACKERMANN, J; DRACH, J et al.Annals of oncology. 2003, Vol 14, Num 11, pp 1667-1672, issn 0923-7534, 6 p.Article

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow TransplantationMOHTY, M; HÜBEL, K; GERALDES, C et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 7, pp 865-872, issn 0268-3369, 8 p.Article

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSFD'ADDIO, A; CURTI, A; KOPETZKY, G et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 3, pp 356-363, issn 0268-3369, 8 p.Article

Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemiaREITER, E; GREINIX, H. T; FISCHER, G et al.Annals of hematology (Print). 1999, Vol 78, Num 11, pp 507-513, issn 0939-5555Article

Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemiaREITER, E; GREINIX, H. T; KALHS, P et al.Annals of hematology (Print). 1998, Vol 77, Num 6, pp 283-286, issn 0939-5555Article

Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)HALTER, J. P; WALRAVEN, Sm Van; SZER, J et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 220-225, issn 0268-3369, 6 p.Article

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationHÜBEL, K; FRESEN, M. M; LANZA, F et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 8, pp 1046-1050, issn 0268-3369, 5 p.Article

Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantationBOEHM, A; SPERR, W. R; RABITSCH, W et al.European journal of clinical investigation. 2008, Vol 38, Num 12, pp 945-952, issn 0014-2972, 8 p.Article

Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplantsKEIL, F; PRINZ, E; RABITSCH, W et al.Leukemia. 2001, Vol 15, Num 3, pp 355-361, issn 0887-6924Conference Paper

Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency : a case report and review of the literatureREITER, E; KALHS, P; KEIL, F et al.Annals of hematology (Print). 1999, Vol 78, Num 4, pp 189-191, issn 0939-5555Article

Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantationKEIL, F; KALHS, P; WOREL, N et al.Annals of hematology (Print). 1999, Vol 78, Num 8, pp 376-379, issn 0939-5555Article

Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patientsPETERS, C; MINKOV, M; GADNER, H et al.British journal of haematology. 1999, Vol 106, Num 3, pp 689-696, issn 0007-1048Article

Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresisDETTKE, M; HLOUSEK, M; KURZ, M et al.Transfusion (Philadelphia, PA). 1998, Vol 38, Num 5, pp 449-453, issn 0041-1132Article